-
1
-
-
16544389343
-
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer. A dose-escalation phase I trial
-
Socinski M.A., Morris D.E., Halle J.S., et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer. A dose-escalation phase I trial. J Clin Oncol 22 (2004) 4341-4350
-
(2004)
J Clin Oncol
, vol.22
, pp. 4341-4350
-
-
Socinski, M.A.1
Morris, D.E.2
Halle, J.S.3
-
2
-
-
0742305722
-
Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma. Long-term results and associations with pathologic response
-
Machtay M., Lee J.H., Stevenson J.P., et al. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma. Long-term results and associations with pathologic response. J Thorac Cardiovasc Surg 127 (2004) 108-113
-
(2004)
J Thorac Cardiovasc Surg
, vol.127
, pp. 108-113
-
-
Machtay, M.1
Lee, J.H.2
Stevenson, J.P.3
-
3
-
-
0141927960
-
Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer
-
Wendland M.M.M., and Sause W.T. Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer. Semin Surg Oncol 21 (2003) 111-121
-
(2003)
Semin Surg Oncol
, vol.21
, pp. 111-121
-
-
Wendland, M.M.M.1
Sause, W.T.2
-
4
-
-
0032858243
-
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
-
Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
-
(1999)
J Clin Oncol
, vol.17
, pp. 2692-2699
-
-
Furuse, K.1
Fukuoka, M.2
Kawahara, M.3
-
5
-
-
7444249045
-
Predictors of acute esophagitis in patients with non small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery
-
Patel A.B., Edelman M.J., Kwok Y., et al. Predictors of acute esophagitis in patients with non small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60 (2004) 1106-1112
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 1106-1112
-
-
Patel, A.B.1
Edelman, M.J.2
Kwok, Y.3
-
6
-
-
0034307213
-
Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus. A multivariate analysis of patients with lung cancer treated with nonoperative therapy
-
Werner-Wasik M., Pequignot E., Leeper D., et al. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus. A multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys 48 (2000) 689-696
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.48
, pp. 689-696
-
-
Werner-Wasik, M.1
Pequignot, E.2
Leeper, D.3
-
7
-
-
1542376214
-
Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma
-
Bradley J., Deasy J.O., Bentzen S., et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 1106-1113
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 1106-1113
-
-
Bradley, J.1
Deasy, J.O.2
Bentzen, S.3
-
8
-
-
18944404259
-
Clinical and dosimetric factors of radiation-induced esophageal injury. Radiation-induced esophageal toxicity
-
Qiao W.B., Zhao Y.H., Zhao Y.B., et al. Clinical and dosimetric factors of radiation-induced esophageal injury. Radiation-induced esophageal toxicity. World J Gastroenterol 11 (2005) 2626-2629
-
(2005)
World J Gastroenterol
, vol.11
, pp. 2626-2629
-
-
Qiao, W.B.1
Zhao, Y.H.2
Zhao, Y.B.3
-
9
-
-
0037298098
-
Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy
-
Singh A.K., Lockett M., and Bradley J.D. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 337-341
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.55
, pp. 337-341
-
-
Singh, A.K.1
Lockett, M.2
Bradley, J.D.3
-
10
-
-
0035479074
-
Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy
-
Hirota S., Tsujino K., Endo M., et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys 51 (2001) 291-295
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.51
, pp. 291-295
-
-
Hirota, S.1
Tsujino, K.2
Endo, M.3
-
11
-
-
0033993435
-
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer
-
Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
-
Sause W., Kolesar P., Taylor S., et al., Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117 (2000) 358-364
-
(2000)
Chest
, vol.117
, pp. 358-364
-
-
Sause, W.1
Kolesar, P.2
Taylor, S.3
-
12
-
-
0031726121
-
Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer
-
Choy H., Akerley W., Safran H., et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 16 (1998) 3316-3322
-
(1998)
J Clin Oncol
, vol.16
, pp. 3316-3322
-
-
Choy, H.1
Akerley, W.2
Safran, H.3
-
13
-
-
0032956133
-
Interfraction interval dose not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy. A multivariate analysis of 1076 RTOG patients
-
Werner-Wasik M., Scott C., Graham M.L., et al. Interfraction interval dose not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy. A multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys 44 (1999) 327-331
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.44
, pp. 327-331
-
-
Werner-Wasik, M.1
Scott, C.2
Graham, M.L.3
-
14
-
-
20444427928
-
Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy
-
Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
-
(2005)
Radiother Oncol
, vol.75
, pp. 157-164
-
-
Belderbos, J.1
Heemsbergen, W.2
Hoogeman, M.3
-
15
-
-
0003418872
-
-
ICRU, Bethesda, MD
-
ICRU Report 50. Prescribing, recording, and reporting photon beam therapy, International Commission on Radiation Units and Measurements (1993), ICRU, Bethesda, MD
-
(1993)
ICRU Report 50. Prescribing, recording, and reporting photon beam therapy, International Commission on Radiation Units and Measurements
-
-
-
16
-
-
0031724258
-
Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung
-
Byhardt R.W., Scott C., Sause W.T., et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42 (1998) 469-478
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.42
, pp. 469-478
-
-
Byhardt, R.W.1
Scott, C.2
Sause, W.T.3
-
17
-
-
0034237791
-
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center affiliate network study)
-
Choy H., Devore R.F., Hande K.R., et al. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center affiliate network study). Int J Radiat Oncol Biol Phys 47 (2000) 931-937
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.47
, pp. 931-937
-
-
Choy, H.1
Devore, R.F.2
Hande, K.R.3
-
18
-
-
18344407670
-
Quantification of radiation-induced regional lung with perfusion imaging
-
Marks L.B., Munley M.T., Spencer D.P., et al. Quantification of radiation-induced regional lung with perfusion imaging. Int J Radiat Oncol Biol Phys 38 (1997) 399-409
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.38
, pp. 399-409
-
-
Marks, L.B.1
Munley, M.T.2
Spencer, D.P.3
-
19
-
-
0032813864
-
Clinical and dosimetric predictors of radiation-induced esophageal toxicity
-
Maguire P.D., Sibley G.S., Zhou S.M., et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 45 (1999) 97-103
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.45
, pp. 97-103
-
-
Maguire, P.D.1
Sibley, G.S.2
Zhou, S.M.3
|